doxifluridine has been researched along with Carcinoma, Transitional Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, A; Baba, Y; Jojima, K; Matsuyama, H; Naito, K; Shimabukuro, T; Suga, A; Suyama, K; Uchiyama, K; Yamamoto, N | 1 |
| Fukuoka, H; Fukushima, S; Hosaka, M; Kinoshita, Y; Kondo, I; Kubota, Y; Miura, T; Miyai, K; Moriyama, M; Shuin, T | 1 |
1 trial(s) available for doxifluridine and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Novel prophylactic effect of doxifluridine in superficial bladder cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Cystectomy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Floxuridine; Follow-Up Studies; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Probability; Proportional Hazards Models; Prospective Studies; Reference Values; Risk Assessment; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms | 2004 |
1 other study(ies) available for doxifluridine and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
[Phase II study of 5'-DFUR (Furtulon) capsule for bladder cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Diarrhea; Drug Administration Schedule; Drug Evaluation; Female; Floxuridine; Humans; Male; Middle Aged; Nausea; Urinary Bladder Neoplasms | 1991 |